Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Matter, Matthias S.; Marquardt, Jens U.; Andersen, Jesper B. et al.
Oncogenic Driver Genes and the Inflammatory Microenvironment Dictate Liver Tumor PhenotypeHEPATOLOGY. Bd. 63. H. 6. 2016 S. 1888-1899
Farthmann, Juliane; Hasenburg, Annette
Oncology Sexuality after gynecological oncology Cancer and Breast CancerGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 76. H. 3. 2016 S. 231-233
Stoffelns, BM; Laspas, Panagiotis; Schmidberger, H et al.
Optische Kohärenztomographie (OCT) bei perkutaner fraktionierter Strahlentherapie eines diffusen Aderhauthämangioms bei Sturge Weber-SyndromKlinische Monatsblätter für Augenheilkunde. Bd. 233. H. 4. 2016 S. 527-9
Grimm, Daniel; Lieb, Jonas; Weyer, Veronika et al.
Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatmentBMC CANCER. Bd. 16. 2016
Koc, Marcin; Kostrubiec, Maciej; Elikowski, Waldemar et al.
Outcome of patients with right heart thrombi: the Right Heart Thrombi European RegistryEUROPEAN RESPIRATORY JOURNAL. Bd. 47. H. 3. 2016 S. 869-875
Schmidt, Marcus
Palbociclib - from Bench to Bedside and BeyondBREAST CARE. Bd. 11. H. 3. 2016 S. 177-181
Hopprich, A.; Guenther, L. D.; Laufenberg-Feldmann, R. et al.
Palliative Sedation on a University Palliative WardDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 141. H. 8. 2016 S. E60-E66
Waisman, Ari; Hoevelmeyer, Nadine; Diefenbach, Andreas et al.
Past, present and future of immunology in MainzCELLULAR IMMUNOLOGY. Bd. 308. 2016 S. 1-6
Distler, Eva; Albrecht, Jana; Brunk, Ariane et al.
Patient-individualized CD8(+) cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient miceINTERNATIONAL JOURNAL OF CANCER. Bd. 138. H. 5. 2016 S. 1256-1268
Hilbert, F.; Gropp-Meier, M.; Schmalfeldt, B. et al.
Patient-reported outcome (PRO) results from the AGO-OVAR 2.20/ENGOT-ov14/PENELOPE double-blind placebo-controlled randomised phase III trial evaluating chemotherapy +/- pertuzumab for platinum-resistant ovarian cancer (PROC)ONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 138-138